Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $118,053,833,450
Number of Records: 1,273
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Endo International$4,847,990,66731
Takeda Pharmaceutical$3,987,516,44732
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentPrimary Offense TypeYearAgency sort iconPenalty Amount
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010AR-AG$18,500,000
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2017CA-INS$1,100,000
Endo PharmaceuticalsEndo Internationaloff-label or unapproved promotion of medical products2022CA-SFCA$10,000,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022CA-SFCA$27,000,000
Teva ParmaceuticalsTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022CA-SFCA$27,000,000
Actavis Kadian, LLCAbbVieMedicare Coverage Gap Discount Program violation2013CMS$116,703
Intermune, Inc.RocheMedicare Coverage Gap Discount Program violation2013CMS$5,641
Intermune, Inc.RocheMedicare Coverage Gap Discount Program violation2013CMS$16,215
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2015CMS$5,909
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2015CMS$9,440
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2016CMS$10,788
Amneal Pharmaceuticals, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2016CMS$12,367
Amneal Pharmaceuticals, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2019CMS$12,968
Wockhardt USAWockhardt LimitedMedicare Coverage Gap Discount Program violation2020CMS$111,824
Alnylam Pharmaceuticals, Inc.Alnylam PharmaceuticalsMedicare Coverage Gap Discount Program violation2023CMS$31,959
Cephalon, Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008CT-AG$6,150,000
Eli Lilly and Co.Eli Lillyoff-label or unapproved promotion of medical products2009CT-AG$25,100,000
Mallinckrodt LLCMallinckrodtControlled Substances Act violation2017DEA$35,000,000
Bristol-Myers Squibb CompanyBristol-Myers Squibboff-label or unapproved promotion of medical products2007DOJ_CIVIL$515,000,000
Medicis Pharmaceutical CorporationBausch Healthoff-label or unapproved promotion of medical products2007DOJ_CIVIL$9,800,000
Endo Health Solutions Inc.Endo Internationaloff-label or unapproved promotion of medical products2014FDA$192,700,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013FDA$2,200,000,000
Wyeth Pharmaceuticals Inc.Pfizeroff-label or unapproved promotion of medical products2013FDA$490,900,000
Par Pharmaceutical Companies Inc.Endo Internationaloff-label or unapproved promotion of medical products2013FDA$45,000,000
GlaxoSmithKline LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2012FDA$3,000,000,000
Abbott Laboratories Inc.AbbVieoff-label or unapproved promotion of medical products2012FDA$1,500,000,000
Cypress Pharmaceutical Inc.Currax Pharmaceuticalsoff-label or unapproved promotion of medical products2012FDA$2,800,000
Merck, Sharp & DohmeMerckoff-label or unapproved promotion of medical products2011FDA$950,000,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2011FDA$14,500,000
Scios Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2011FDA$85,000,000
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2011FDA$25,000,000
UCB Inc.UCBoff-label or unapproved promotion of medical products2011FDA$34,000,000
Forest Pharmaceuticals Inc.AbbVieoff-label or unapproved promotion of medical products2011FDA$164,000,000
Elan Corporation PLCPerrigooff-label or unapproved promotion of medical products2010FDA$203,000,000
Eisai Inc.Eisaioff-label or unapproved promotion of medical products2010FDA$11,000,000
Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$422,500,000
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010FDA$600,000,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonoff-label or unapproved promotion of medical products2010FDA$81,000,000
AstraZeneca LPAstraZenecaoff-label or unapproved promotion of medical products2010FDA$520,000,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2012FDA$762,000,000
Warner Chilcott PLCAbbVieoff-label or unapproved promotion of medical products2015FDA$125,000,000
Shire Pharmaceuticals LLCTakeda Pharmaceuticaloff-label or unapproved promotion of medical products2014FDA$56,500,000
Boehringer Ingelheim Pharmaceuticals Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2012FDA$95,000,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$72,500,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2009FDA$2,300,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009FDA$1,415,000,000
Cephalon IncTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008FDA$425,000,000
Otsuka American Pharmaceutical Inc.Otsuka Pharmaceuticaloff-label or unapproved promotion of medical products2008FDA$4,000,000
Serono, S.A.Merck KGaA (EMD)off-label or unapproved promotion of medical products2005FDA$704,000,000
Warner-LambertPfizeroff-label or unapproved promotion of medical products2004FDA$430,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2005FDA$36,000,000
InterMune Inc.Rocheoff-label or unapproved promotion of medical products2006FDA$36,900,000
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc.Endo Internationaloff-label or unapproved promotion of medical products2022FL-AG$65,000,000
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022FL-AG$278,826,499
Allergan Ltd. et al.AbbVieoff-label or unapproved promotion of medical products2022FL-AG$134,200,000
Endo Health Solutions and Endo PharmaceuticalsEndo Internationaloff-label or unapproved promotion of medical products2022FL-AG$65,000,000
Glenmark Pharmaceuticals, Inc.Glenmark PharmaceuticalsHHS civil monetary penalties2015HHSOIG$2,887,300
Sandoz, Inc.Sandoz GroupHHS civil monetary penalties2015HHSOIG$12,640,000
Sandoz, Inc.Sandoz GroupHHS civil monetary penalties2011HHSOIG$230,000
Advanced Neuromodulation Systems, Inc.Abbott LaboratoriesHHS civil monetary penalties2007HHSOIG$2,950,000
Alnylam Pharmaceuticals, Inc.Alnylam PharmaceuticalsHHS civil monetary penalties2024HHSOIG$170,000
Eli Lilly and Co.Eli Lillyoff-label or unapproved promotion of medical products2009ID-AG$13,000,000
AstraZenecaAstraZenecaoff-label or unapproved promotion of medical products2013KY-AG$5,500,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2010KY-AG$3,700,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2009KY-AG$661,860
Teva Pharmaceuticals, Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2023KY-AG$71,477,474
Allergan PLCAbbVieoff-label or unapproved promotion of medical products2023KY-AG$48,666,145
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010LA-AG$20,000,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2013MA-AG$15,100,000
Mylan Specialty, L.P.Viatrisoff-label or unapproved promotion of medical products2013MA-AG$250,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2013MA-AG$375,000
GlaxoSmithKline, LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2013MD-AG$15,000,000
TevaTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2024MD-AG$70,281,867
AllerganAbbVieoff-label or unapproved promotion of medical products2024MD-AG$38,166,450
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010MS-AG$18,500,000
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2014MT-AG$5,900,000
Abbott LaboratoriesAbbVieoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $339,148,643
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $14,750,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2015MULTI-AG$71,000,000
AstraZeneca PharmaceuticalsAstraZenecaoff-label or unapproved promotion of medical products2011MULTI-AG$68,500,000
AstraZeneca Pharmaceuticals LPAstraZenecaoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
Boehringer Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2017MULTI-AG$13,500,000
Boehringer-Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000
Bristol-Myers SquibbBristol-Myers Squibboff-label or unapproved promotion of medical products2016MULTI-AG$19,500,000
Celgene Corp.Bristol-Myers Squibboff-label or unapproved promotion of medical products2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000
Cephalon Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000
Eisai Inc.Eisaioff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,658,249
Elan Corp.Perrigooff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2008MULTI-AG$62,000,000
Endo Health SolutionEndo Internationaloff-label or unapproved promotion of medical products2014MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000
Genentech Inc.Rocheoff-label or unapproved promotion of medical products2000MULTI-AG$19,000,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391
Inspire PharmaceuticalsMerckoff-label or unapproved promotion of medical products2015MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000
InterMune Inc.Rocheoff-label or unapproved promotion of medical products2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000
ISTA Pharmaceuticals, Inc.Bausch Healthoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $390,253
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2012MULTI-AG$181,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $541,000,000
Medicis Pharmaceutical CorporationBausch Healthoff-label or unapproved promotion of medical products2007MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,000,000
Merck Sharp & Dohme Corp.Merckoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $201,975,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.